News | Colonoscopy Systems | October 27, 2016

Check-Cap Announces Presentation of Clinical Data on Preparation-Free Colorectal Cancer Screening Capsule

Data from U.S. and European studies demonstrate safety and detection of polyps

Check-Cap, colorectal cancer screening capsule, ACG, UEGW, clinical data, colorectal cancer screening

October 27, 2016 — Check-Cap Ltd. announced additional clinical data was recently presented on its ingestible capsule for preparation-free, minimally-invasive colorectal cancer screening. The research was presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting, Oct. 14-19 in Las Vegas, and at the United European Gastroenterology Week (UEGW), Oct. 15-19 in Vienna.

During ACG, a video abstract entitled "A Preparation-Free X-Ray Imaging Capsule for Colon Cancer Screening" presented case studies on the use of the system in three patients enrolled in the company's ongoing clinical feasibility study. Clinical review showed the system's viewing modes to examine the inner surface of colon segments in order to identify and locate flat sessile and pedunculated polyps that were confirmed by optical colonoscopy.

"Although colorectal cancer is the second leading cause of cancer deaths in the U.S., rigorous evidence suggests that better screening adherence can lead to significantly improved survival rates," said study presenter Seth A. Gross, M.D., associate professor and chief of gastroenterology at Tisch Hospital, NYU Langone Medical Center. "These data reinforce previous findings that a non-invasive, preparation-free alternative to traditional optical colonoscopy may be a safe and effective alternative for the significant portion of the population who do not currently undergo routine screening evaluation."

A poster presentation at UEGW entitled "A Novel Preparation-Free X-Ray Imaging Capsule for Colon Cancer Screening: Correlation between Capsule and Colonoscopic Clinical Findings" provided an update on preliminary data from the company's ongoing clinical feasibility study evaluating the Check-Cap system in 66 volunteers aged 41-74 years. The study tracked the entire passage of the capsule through the alimentary tract using radiofrequency telemetry and Check-Cap's proprietary capsule position tracking system.

Findings from the study demonstrated the capability of the system to identify polyps and provide segmental location and morphology information, as confirmed by colonoscopy. All capsules were swallowed naturally without adverse events and excreted after an average transit time of 62 hours. Enrolled subjects were exposed to ultra-low doses of radiation with an average total exposure of 0.06 ± 0.04 mSv. While colonic polyps were clearly identified and reconstructed by the system, the efficacy of this colon screening modality will be further evaluated in planned multi-center studies.

Check-Cap anticipates submitting data from this study for CE Marking in the first half of 2017 and initiating a U.S. pivotal trial in 2018.

For more information: www.check-cap.com

Related Content

Bay Labs Announces New Echocardiography Guidance Software Data at ASE 2019 Scientific Sessions
News | Cardiovascular Ultrasound | June 20, 2019
Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational guidance software...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
Utah Valley Hospital Purchases Nine Carestream Imaging Systems
News | Digital Radiography (DR) | June 12, 2019
Utah Valley Hospital (Provo, Utah) has installed nine Carestream imaging systems that equip its radiology staff to...
SIIM and ACR Host Machine Learning Challenge for Pneumothorax Detection and Localization
News | Artificial Intelligence | June 03, 2019
The Society for Imaging Informatics in Medicine (SIIM) and the American College of Radiology (ACR) are collaborating...
AI Biomarker Demonstrates High Predictive Power for Lung Cancer Immunotherapy
News | Artificial Intelligence | May 31, 2019
Lunit announced an abstract presentation of its artificial intelligence (AI) precision medicine research portfolio at...
Dynamic Digital Radiography Used to Assess Undifferentiated Dyspnea
News | Digital Radiography (DR) | May 29, 2019
A clinical study presented at the American Thoracic Society (ATS) 2019 annual meeting, May 17-22 in Dallas, described...
Leica Biosystems Receives FDA Clearance for Aperio AT2 DX Digital Pathology System
Technology | Digital Pathology | May 29, 2019
Leica Biosystems has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX...
New Blood Test Detects Colorectal Cancer Recurrence Up to 16.5 Months Earlier
News | Oncology Diagnostics | May 28, 2019
A new clinical study shows that Natera's Signatera test identified colorectal cancer recurrence up to 16.5 months...